Table 4

Cancer research investment awards and funding by funding agency (excluding CRUK)

FunderAll funders where investment data were available
Number of awardsPercentage of totalSum investment (£)Percentage of totalMean award, £ (SD)Median award, £ (IQR)
MRC76817.9%£837 649 87535.1%1 090 690 (1 770 533)504 606 (305 375–1 153 374)
Charity (excluding Wellcome and CRUK)169939.5%£415 189 09317.4%244 372 (391 813)151 912 (81 000–223 244)
Department of Health58613.6%£413 421 82317.3%705 498 (2 675 223)232 173 (102 391–471 236)
BBSRC51111.9%£223 651 0029.4%437 673 (388 793)373 356 (267 848–501 592)
EPSRC3568.3%£201 861 6238.5%567 027 (972 696)306 906 (144 056–604 016)
Wellcome1934.5%£140 425 8055.9%727 594 (1 679 370)226 761 (164 547–427 455)
European Commission (ERC)501.2%£78 757 4473.3%1 575 149 (731 858)1 409 678 (1 252 574–1 830 017)
Other1363.2%£77 195 6503.2%567 615 (1 901 202)129 944 (69 309–263 613)
Total4299£2 388 152 318555 513 (1 429 510)231 559 (114 619–487 063)
  • All investment reported in 2013 UK pounds.

  • BBSRC, Biotechnology and Biological Sciences Research Council; CRUK, Cancer Research UK; EPSRC, Engineering and Physical Science Research Council; ERC, European Research Council; MRC, Medical Research Council.

  • ERC European Research Council